In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...
LoveBScott on MSN
MISTR & SISTR Launch First-Ever National PrEP Day: A Bold Move to End HIV in the U.S.
Oct. 10, 2025, is officially the first-ever National PrEP Day, and MISTR and SISTR are going big. Their goal? Get 10,000 new ...
HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...
After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. “Seeing that people who look like me, who hang out at the same ...
A pharmacist pours pills of Truvada, a PrEP medication, into a bottle. A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive medication, the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results